Fingerprint
Dive into the research topics of 'A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically